Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients

INTRODUCTION: The aim of this study was to determine the efficacy of early tocilizumab treatment for hospitalized patients with COVID-19 disease. METHODS: Open-label randomized phase II clinical trial investigating tocilizumab in patients with proven COVID-19 admitted to the general ward and in need...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutgers, Abraham, Westerweel, Peter E., van der Holt, Bronno, Postma, Simone, van Vonderen, Marit G. A., Piersma, Djura P., Postma, Douwe, van den Berge, Maarten, Jong, Eefje, de Vries, Marten, van der Burg, Leonie, Huugen, Dennis, van der Poel, Marjolein, Kampschreur, Linda M., Nijland, Marcel, Strijbos, Jaap H., Tamminga, Menno, Mutsaers, Pim G. N. J., Schol-Gelok, Suzanne, Dijkstra-Tiekstra, Margriet, Sidorenkov, Grigory, Vincenten, Julien, van Geffen, Wouter H., Knoester, Marjolein, Kosterink, Jos, Gans, Reinold, Stegeman, Coen, Huls, Gerwin, van Meerten, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374226/
https://www.ncbi.nlm.nih.gov/pubmed/35960720
http://dx.doi.org/10.1371/journal.pone.0271807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374226/
https://www.ncbi.nlm.nih.gov/pubmed/35960720
http://dx.doi.org/10.1371/journal.pone.0271807

Ejemplares similares